Evidence map›Paper›PMID 25620271›Full record

ReviewJournal of bioenergetics and biomembranes2016

Sphingolipids and mitochondrial apoptosis.

Gauri A Patwardhan, Levi J Beverly, Leah J Siskind

Abstract readReview
In one paragraph

Review in Journal of bioenergetics and biomembranes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 136 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gauri A PatwardhanDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA.
Levi J BeverlyDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA.
Leah J SiskindDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA. leah.siskind@louisville.edu.
University of Louisville · US

Funding

Role of Ceramide-induced Kidney Cell Death in Acute Kidney InjuryR01DK093462 · NIDDK · UNIVERSITY OF LOUISVILLE · PI SISKIND, LEAH J · 2012 to 2016
$1.6M
NIDDK NIH HHS R01 DK093462
6 · The paper itself

Abstract

The sphingolipid family of lipids modulate several cellular processes, including proliferation, cell cycle regulation, inflammatory signaling pathways, and cell death. Several members of the sphingolipid pathway have opposing functions and thus imbalances in sphingolipid metabolism result in deregulated cellular processes, which cause or contribute to diseases and disorders in humans. A key cellular process regulated by sphingolipids is apoptosis, or programmed cell death. Sphingolipids play an important role in both extrinsic and intrinsic apoptotic pathways depending on the stimuli, cell type and cellular response to the stress. During mitochondrial-mediated apoptosis, multiple pathways converge on mitochondria and induce mitochondrial outer membrane permeabilization (MOMP). MOMP results in the release of intermembrane space proteins such as cytochrome c and Apaf1 into the cytosol where they activate the caspases and DNases that execute cell death. The precise molecular components of the pore(s) responsible for MOMP are unknown, but sphingolipids are thought to play a role. Here, we review evidence for a role of sphingolipids in the induction of mitochondrial-mediated apoptosis with a focus on potential underlying molecular mechanisms by which altered sphingolipid metabolism indirectly or directly induce MOMP. Data available on these mechanisms is reviewed, and the focus and limitations of previous and current studies are discussed to present important unanswered questions and potential future directions.

Indexed as

AnimalsApoptosisApoptotic Protease-Activating Factor 1HumansMitochondriaMitochondrial MembranesPermeabilitySphingolipidsAPAF1 protein, humanApoptotic Protease-Activating Factor 1SphingolipidsApoptosisBcl-2 proteinsCancerCeramideMitochondriaSphingolipid

Identifiers

PMID25620271
PMCPMC5434644
OpenAlexW2044119772

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.